This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Feline Leukemia Virus Viral Myc Transforming Protein (MYC)
Product Overview
BioVenic's Recombinant Feline Leukemia Virus Viral Myc Transforming Protein (MYC) is a recombinant protein expressed from E.coli. Its predicted molecular weight is 9.4 kDa. The purity is>85% (SDS-PAGE).
Specifications
Target Information
Feline leukemia virus viral myc transforming protein (MYC) is a viral oncogene product that contributes to the pathogenesis of FeLV-associated lymphomas and leukemias. It is involved in the transformation of host cells by activating cellular proto-oncogenes, leading to uncontrolled cell proliferation. In veterinary medicine, MYC is used as a biomarker for studying the molecular mechanisms of FeLV-induced cancers and for developing diagnostic tools to detect FeLV infections and associated malignancies. Additionally, understanding MYC's role helps in designing targeted therapies to inhibit viral oncogenesis.
Shipping and Storage
This product is shipped with ice packs. Lyophilized protein can be stored at -20°C for 1 year. After reconstitution, the protein solution can be stored at 2-8°C for 2-7 days.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquot the reconstituted solution to minimize freeze-thaw cycles.